magnolol has been researched along with cyclin d1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YL; Chen, SC; Cheng, JJ; Wang, DL | 1 |
| Aggarwal, BB; Ahn, KS; Arbiser, JL; Sethi, G; Shishodia, S; Sung, B | 1 |
| Cheng, YT; Chuang, TC; Fang, GS; Hsu, SC; Ou, CC; Shao, WS; Wang, V; Wu, K | 1 |
| Catalli, A; Hurta, RA; McDougall, L; McKeown, BT | 1 |
| Bao, R; Cao, Y; Gao, G; Gu, J; Li, M; Liu, S; Liu, Y; Lu, J; Mu, J; Shu, Y; Wang, X; Wang, Z; Weng, H; Wu, W; Wu, X; Zhang, B; Zhang, F; Zhang, N; Zhu, J | 1 |
| Li, H; Wen, H; Zhou, S | 1 |
6 other study(ies) available for magnolol and cyclin d1
| Article | Year |
|---|---|
Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Blotting, Western; Cattle; Cell Adhesion; Cell Line; Cells, Cultured; Chemokine CCL2; Cyclin D1; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Endothelial Cells; Gene Expression; Intercellular Adhesion Molecule-1; Interleukin-6; Lignans; Luciferases; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Recombinant Fusion Proteins; STAT3 Transcription Factor | 2006 |
Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
Topics: Animals; Apoptosis; Biphenyl Compounds; Carrier Proteins; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Synergism; Genes, myc; Humans; I-kappa B Proteins; Lignans; Matrix Metalloproteinase 9; Membrane Glycoproteins; Membrane Proteins; Mice; Molecular Structure; NF-kappa B; NF-KappaB Inhibitor alpha; Osteoclasts; Osteogenesis; Phosphorylation; Promoter Regions, Genetic; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Synaptotagmin I; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2006 |
Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Topics: Biphenyl Compounds; Caspase 3; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclin D1; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lignans; Neoplasm Metastasis; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2011 |
Magnolol causes alterations in the cell cycle in androgen insensitive human prostate cancer cells in vitro by affecting expression of key cell cycle regulatory proteins.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin A; Cyclin B1; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Humans; Lignans; Magnolia; Male; Plant Extracts; Prostatic Neoplasms | 2014 |
Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase Cell Cycle Checkpoints; Gallbladder Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Medicine, Chinese Traditional; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Nitric Oxide Synthase; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
Magnolol induces apoptosis in osteosarcoma cells via G0/G1 phase arrest and p53-mediated mitochondrial pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Osteoblasts; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resting Phase, Cell Cycle; Signal Transduction; Tumor Suppressor Protein p53 | 2019 |